Binding to downstream targets. This promoted mouse somatic cell reprogramming byBinding to downstream targets. This

Binding to downstream targets. This promoted mouse somatic cell reprogramming by
Binding to downstream targets. This promoted mouse somatic cell reprogramming by expression of pluripotent genes [51]. In addition, we also identified the CASP7 (Apoptosis) gene as a positive target of the SREBP-1 get RG7666 protein [52]. NQO1, an NADPH dehydrogenase implicated in the detoxification system, has been shown to directly interact with NME1 and TP53 (Cancer Pathway) in studies retrieved from the BioGrid database [48]. Furthermore, NQO1 stabilized TP53 and partially inhibited itsDurand et al. BMC Genomics (2017) 18:Page 17 ofdegradation under conditions of oxidative stress, making it a possible contributor to tumor development [53]. Putative homologs of CHECK2 and INSIG1 from Saccharomyces cerevisiae, of DHCR7 and CYP51A1 and of CYP2B6 and NSDHL were found to have physical interactions in Intact and BioGRID databases, which may explain the relations observed in our network [48, 54]. Putative homologs of CYP2B6 and NR1H4 in Caenorhabditis elegans were also found in these databases. Further studies will be required to understand this relation. Visualization of our 113 genes-network, on the basis of two topological parameters, the degree and the clustering coefficient, highlighted 4 modules related to functional gene groups characterized by different levels of clustering coefficient and node degree (Additional file 8: Figure S6A). Because chemotherapy is commonly used to treat colon cancer patients, we looked at the activity of prototypic anticancer drugs and/or Lovastatin PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28461567 on expression of deregulated genes occupying central places within the networks. At first sight, a drug or drug combination that would oppose the observed deregulation of such “major genes” would be useful, provided these genes are central to normal tissue homeostasis. Conversely, drugs that would enhance the deregulation effects might be inappropriate, if the given genes are important for cancer initiation or progression, according to their expression level at baseline. The IL8 gene, which was clearly over-expressed in CRC, was further upregulated in HT29 cells in response to all drugs or drug combinations, except in response to Lovastatin that decreased its expression. In the case of this important inflammatory mediator, it would appear that none of the common anticancer drugs used would contribute to inflammation reduction, at least at the colon cell level. Similarly, CHECK2 was always induced (HT29 cells), except in response to Lovastatin that decreased it. In this case, however, it might be beneficial to treat CRC patients bearing tumors addicted to CHECK2 for growth with common CRC anticancer drugs and CHECK2 inhibitors [55]. Several actions could be taken to reestablish normal transcript levels through using selected drugs: i) targeting proteins with high numbers of interactions (hubs proteins: large size on Additional file 8: Figure S6) or ii) targeting one protein in an interacting module (with a high clustering coefficient (yellow/orange color on Additional file 8: Figure S6) (for example the Wnt or the Lipoprotein signaling and cholesterol metabolism module). Interrogation of the STITCH database (Search Tools for Interactions of Chemicals) [29] for associations between deregulated genes in CRC and the 3 chemotherapeutic drugs tested in our study showed that these two types of genes could be targeted (Additional file 10). On the other hand, none of the drugs targeted members from the Wnt signaling pathway, except CCND1 that could be affected by Oxaliplatin and.